ERBB2 and breast carcinoma: The authors also enrolled two human patients with primary breast cancer for an initial in-human investigation of 68Ga-NOTA-MAL-Cys-MZHER2:342 PET imaging, one with HER2-positive disease and another with HER2-negative disease.